Medical News

RSS

Lawsuit to be launched over breast cancer gene patent

BRCA1 and BRCA2 are two genes that have been identified to hold a key to women’s susceptibility to get breast or ovarian cancer. Changes also known as mutations in these genes are significant in women who go on to develop breast or ovarian cancer. Melbourne-based company Genetic Technologies Limited (GTL) has the exclusive license from American biotechnology company Myriad Genetics to carry out testing for the genes in Australia. Myriad holds a patent for these genes.

7 Jun 2010

People conflicted and stymied between public and private long term care insurance

The CLASS Act, part of the new health reform law (the Patient Protection and Affordable Care Act), will offer a type of long term care insurance for working people and others who may become disabled. But confusion and doubt are widespread. "Many wonder how the CLASS Act will affect them personally," says Jonas Roeser, Senior Vice President of Marketing & Operations for LTC Financial Partners LLC, one of the nation's most experienced long term care insurance agencies.

7 Jun 2010

Medtronic launches iPro2 Professional CGM system to help improve diabetes management

Medtronic, Inc. announced today the launch of iPro2 Professional CGM, a continuous glucose monitoring system used by physicians to help improve diabetes management, in 49 countries around the world. This simplified, yet more advanced fourth-generation CGM system is valuable for detecting high and low glucose fluctuations that can lead to dangerous health complications, which often go undetected with traditional A1C tests (a measurement of glucose control over a two-to-three-month period) and glucose meter measurements.

7 Jun 2010

CancerForward: The Foundation for Cancer Survivors launched

The numbers are stark. An astounding three out of every four U.S. families include one family member diagnosed with cancer. Worldwide, 28 million people - more than 12 million people in the U.S. alone - are now living with cancer. While the survivor population continues to grow, few public resources exist to promote the exchange of education and experiential information among survivors.

7 Jun 2010

Hana Biosciences signs Investment Agreement with Warburg Pincus and Deerfield Management

Hana Biosciences Inc., a biopharmaceutical company focused on strengthening the foundation of cancer care, today announced that it has entered into an Investment Agreement with Warburg Pincus and Deerfield Management for the sale of up to $100 million in preferred stock. Warburg Pincus, the lead investor in the financing, is a new investor in Hana, and Deerfield is the company's largest existing shareholder prior to this financing.

7 Jun 2010

EKOS receives $2.7M grant to develop product for treatment of ICH

EKOS Corporation announced today that they received a $2.7 million grant from the National Institutes of Health for the development of a product to provide therapy for intracerebral hemorrhagic stroke.

7 Jun 2010

Targeted therapy that benefits patients with metastatic colon cancer fails to help patients with stage III cancer

To the surprise of researchers at Mayo Clinic who led a national clinical trial, a targeted therapy that provides benefit to patients with metastatic colon cancer has failed to help patients with less advanced, stage III cancer. In fact, patients who used the agent, cetuximab, with chemotherapy had outcomes slightly inferior to patients treated with chemotherapy alone.

7 Jun 2010

MHRA issues Supplementary Accreditation to Chiltern

Chiltern International Limited, a global contract research organization, has announced that Chiltern Early Phase Limited, based in Ninewells Hospital and Medical School in Dundee, Scotland, has achieved Supplementary Accreditation from the Medicines and Healthcare products Regulatory Agency.

7 Jun 2010

B2Discovery rallies business leaders in support of excellence in cancer research

The Institute for Research in Immunology and Cancer (IRIC) of the Universit- de Montr-al launches B2Discovery, a new research funding model that brings together the private sector and the biomedical research community to help accelerate the discovery of new anti-cancer therapeutics. Inspired by B2ten, which contributed to the success of several Canadian athletes at the Vancouver Winter Olympics, B2Discovery's mission is to partner entrepreneurs with IRIC's cancer investigators to finance novel and promising research projects not currently funded by public granting agencies.

7 Jun 2010

Assured Pharmacy launches new website

Assured Pharmacy, a pharmacy service healthcare organization operating a chain of specialty pharmacies providing advanced prescription medication fulfillment solutions to sufferers of chronic pain, is pleased to announce the launch of its new website: www.assuredrxservices.com.

7 Jun 2010

First Edition: News coverage on Dems' health reform campaign; Medicare fees; Medical marijuana

In his latest Kaiser Health News column, done in collaboration with The New Republic, Jonathan Cohn writes: "Will health care reform reduce spending on health care too little? Or too much? Over the last several days, one respected authority made a version of the former argument while another made a version of the latter--offering a reminder of why reform is so complicated and why the new law, for all its imperfections, is still an important step forward" (Kaiser Health News).

7 Jun 2010

Isobionics finalizes fermentation process for production of natural Valencene Pure

Isobionics has finalized the development of a breakthrough fermentation process for production of its natural Valencene Pure. This product, which is an aroma substance for the food, beverage, flavor and fragrance industry, is now available on a commercial scale. Compared with conventional valencene, which is produced from oranges, it offers the advantage of high purity and constant quality.

7 Jun 2010

Masimo announces full market release of Rainbow Acoustic Monitoring to provide RRa

Masimo, the inventor of Pulse CO-Oximetry and Measure-Through Motion and Low Perfusion pulse oximetry, announced today the full market release of its latest medical technology breakthrough—Masimo Rainbow Acoustic Monitoring— providing continuous and noninvasive respiration rate that is accurate, easy-to-use, and enhances patient tolerance.

7 Jun 2010

New GUM PerioBalance helps maintain oral health

Over 50 percent of Americans state they have moderate stress levels caused by balancing the demands of busy families and careers. However, many are unaware that stressful living, illness, poor diet or inadequate oral hygiene can disrupt your oral balance and allow bad bacteria to thrive causing plaque buildup, poor gum health and bad breath. A balanced oral environment is essential for healthy teeth and gums, just as it is for overall wellness.

7 Jun 2010

Oslo University Hospital, Induct announce long term strategic partnership Agreement

Oslo University Hospital and Induct Software AS, "The Open Innovation Company," today announced a long term strategic partnership Agreement under which the parties will work together to help Oslo University Hospital achieve its goal of becoming the world leader in healthcare innovation.

7 Jun 2010

Parents pressure schools to comply with IDEA or face legal action regarding students with ASD

School districts across the U.S. struggle with the combination of two harsh realities: an increasing intensity of budget cuts for 2010-11, and complying with the federal Individuals with Disabilities Education Act which guarantees "free appropriate" education to all disabled students including the growing number of students with an Autism Spectrum Disorder.

7 Jun 2010

Sentrx achieves Gold Partner status in OPN

Sentrx, a leading provider of drug safety services to the life sciences industry, has achieved Gold Partner status in the Oracle PartnerNetwork. Sentrx will provide life sciences companies with support for Oracle clinical solutions, emphasizing its expertise in drug safety systems, safety data management and adverse event reporting software, processes and consulting expertise.

7 Jun 2010

Medical News

Lawsuit to be launched over breast cancer gene patent

People conflicted and stymied between public and private long term care insurance

Medtronic launches iPro2 Professional CGM system to help improve diabetes management

CancerForward: The Foundation for Cancer Survivors launched

Hana Biosciences signs Investment Agreement with Warburg Pincus and Deerfield Management

EKOS receives $2.7M grant to develop product for treatment of ICH

Targeted therapy that benefits patients with metastatic colon cancer fails to help patients with stage III cancer

MHRA issues Supplementary Accreditation to Chiltern

B2Discovery rallies business leaders in support of excellence in cancer research

Assured Pharmacy launches new website

First Edition: News coverage on Dems' health reform campaign; Medicare fees; Medical marijuana

Isobionics finalizes fermentation process for production of natural Valencene Pure

Masimo announces full market release of Rainbow Acoustic Monitoring to provide RRa

New GUM PerioBalance helps maintain oral health

Oslo University Hospital, Induct announce long term strategic partnership Agreement

Parents pressure schools to comply with IDEA or face legal action regarding students with ASD

Sentrx achieves Gold Partner status in OPN

NPWT clinical hotline for patients

Ten prevention tips to stay safe from infection and illness during summer camp

UBMD selects Allscripts EHR solution to help its physicians enhance quality of patient care

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Shaping the future of lab automation through AI and robotics

Latest News